So-called silent mutations have no effect on the composition of a protein. They are therefore not considered to promote cancer. However, scientists from the German Consortium for Translational Cancer…
PSMA-binding agents specifically dock onto prostate cancer cells. Coupled to diagnostic or therapeutic radionuclides, they can improve the diagnosis and treatment of prostate cancer. Scientists from…
A research team led by Kiel senior professor Thomas F. Meyer reveals transformation of colon organoids in vitro
Autoimmune diseases, in which the body's own immune system attacks healthy tissue, can be life-threatening and can impact all organs. A research team at the Technical University of Munich (TUM) has…
During embryonic brain development, neural stem cells pass through a series of strictly regulated development phases. A mutation in a protein that packs our neatly folded DNA in the cell nucleus…
Anton Henssen of the ECRC has been awarded the Kind Philipp Award for Pediatric Oncology Research for his study of ring-shaped DNA and its significance in the development of childhood neuroblastoma. A…
Prof. Jürgen Ruland, from TUM’s Rechts der Isar Hospital at the Partner Site of the German Consortium for Translational Cancer Research (DKTK), will receive the 2021 Gottfried Wilhelm Leibniz Prize.…
End of October 2020, the annual DKTK Retreat of the partner site Frankfurt/Mainz took place for the 6th time. Joining forces with the Frankfurt Cancer Institute (FCI) and the Mildred Scheel Career…
The new Joint Imaging Platform – JIP for short – is a flexible, decentralized analysis platform for medical images. The JIP was initially developed for the German Cancer Consortium (DKTK) sites. It is…
Tumors of the pancreas are particularly feared. They are usually discovered late and mortality is high. Until now, no targeted and personalized therapies exist. Scientists at the German Cancer…
Molecular biologist Roberto Bonasio from the University of Pennsylvania will be honoured for his outstanding research in the field of epigenetics with the Max Planck-Humboldt Research Award, which is…
In September 2020, the DKTK partner site München issued an internal call for proposals with the aim of selecting and funding translational oncological research projects proposed by early-career…
Dieses Jahr müssen Veranstaltungen aufgrund der COVID-19-Pandemie umgeplant werden. Dies galt auch für den Wissenschaftlichen DKTK-Retreat am 5. Oktober 2020, welcher dieses Jahr in einem virtuellen…
The European Research Council (ERC) grants are considered a particularly honorable distinction for scientists at all career levels. With its "Starting Grants", the ERC aims to pave the way for…
HARPOON (HArmonization of Reporting in PrecisiOn Oncology), the first DKTK workshop on harmonization of molecular tumor boards, took place on July 9 and 10. More than 130 physicians and scientists…
Cancel or postpone? This decision had to be made for almost all planned events in 2020 so far to avoid health risks for potential participants due to COVID19. To cancel was not an option, so the 7th…
cientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and the National Center for Tumor Diseases Dresden (NCT/UCC), together with an international team of researchers, have succeeded in…
Chromothripsis is a form of genome instability by which one or a few chromosomes virtually "explode(s)" in a presumably single catastrophic event. According to current opinion, chromothripsis occurs…
One of the main features of colorectal cancer is that there are considerable differences between the tumors of individual patients - at genetic level and hence in terms of the response to treatment…
Cancer patients are particularly at risk for infections because of their disease and its treatment. Due to the rapid spread of the coronavirus in Europe, cancer centers within a short period were…